Edesa Biotech disclosed a public offering of shares priced at $5.50 each, aiming to raise $25 million in gross proceeds. The company did not provide additional details on the use of proceeds or allocation plans in the announcement.
Further specifics regarding the offering structure or investor demand were not immediately available.
